McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


Trump-Iran Tensions Keep Oil Prices Elevated Amid Hormuz Supply Fears
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Trump to Visit China for Key U.S.-China Summit With Xi Jinping
Ibiden Stock Surges as AI Chip Demand Boosts Profit Outlook
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 



